The purpose of the company is to research, develop, manufacture, exploit, acquire, trade, license and distribute pharmaceutical, medical and diagnostic products and technologies of all kinds, including, but not limited to, radiopharmaceuticals for imaging and therapy. The company may participate in other companies, acquire, exploit, manage and dispose of real estate and intellectual property rights, establish subsidiaries and branches in Switzerland and abroad, and perform all legal acts that may be necessary or useful for the purpose of the company or to promote its development or that of group companies. The company may grant direct or indirect financing to third parties, including companies in which it has a direct or indirect interest, its direct or indirect shareholders, and companies in which such parties have a direct or indirect interest, whether through loans or other financing, and provide security for their liabilities of any kind, including by way of pledges on or fiduciary transfers of the company's assets or guarantees of any kind, whether against payment or not.